Neuroscience

A new mutation behind synucleinopathies

Parkinson's disease and Lewy body dementia belong to a family of neurodegenerative disorders called synucleinopathies because they are caused by the pathological accumulation of protein alpha-synuclein into structures called ...

Parkinson's & Movement disorders

Researchers stimulate improvements in Parkinson's treatment

New research led by QIMR Berghofer Medical Research Institute has identified ways to make the most widely-used advanced treatment for Parkinson's disease—deep brain stimulation therapy—more effective and safer.

Parkinson's & Movement disorders

World-first: A biomarker that can diagnose Parkinson's disease

Researchers at Kobe University and Hiroshima University have successfully developed a biomarker that will enable Parkinson's disease to be rapidly and inexpensively diagnosed from blood serum samples.

page 13 from 40